|
|
| MRD / Regn No. |
: 20250000974 |
Date |
: 09/06/2026 |
| Patient Name |
: Tapan Kumar Naskar |
Age & Gender |
: 72 Yrs. / Male |
| Contact No. |
: 9425230260 |
UHID |
: |
| Ht / Wt / BMI |
: 164 / 60.2 / 22.38 |
BP S / BP D |
: 130 / 70 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
TYPE 2 DM (08/Dec/1991) | A2G3 DKD (10/Dec/2025) | NAFLD (10/Dec/2025) | |
|
Subjective |
: |
TYPE 2 DM SINCE 1991,PCI 2004,HAD A SUBMACULAR BLEED
|
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM,NT PRO BNP AGE APPROPRIATE,ECG OLD INFERIOR INFARCT,FUNDUS CHANGES DR,INCREASE FIB4 SCORE,A2G3 DKD,S2 F0 MASLD |
|
Plan |
: |
CONTINUE CURRENT MEDICATIONS,SEE ME IN 2 MONTHS |
|
| Salient Investigations |
: |
GLYCOSYLATED HEMOGLOBIN (HBA1C): 7.4 % | POST PRANDIAL GLUCOSE (2HPP): 121 mg/dL | UREA: 57 mg/dL | CREATININE: 1.5 mg/dL | EGFR EGLOMERULAR FILTRATION RATE: 48.98 mL/min/1.73m2 | ESR: 7 mm/hour | HEMOGLOBIN: 15.0 g/dL | PCV: 46.6 % | PLATELETS: 119 thou cells/ ul |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES |
SQ |
24-0-18 UNITS |
BEFORE FOOD
|
TILL NEXT VISIT |
| MAY CAUSE HYPOGLYCEMIA | |
|
2 |
TABLET EMPAGLIFLOZIN
EMPAPRO
Medicine For DIABETES HEART KIDNEY PROTECTION |
PO |
|
|
|
| MAY CAUSE GENITOURINARY INFECTION | |
|
3 |
TELMISARTAN 40 MG
ERITEL 40 MG |
|
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE HIGH POTASSIUM | |
|
4 |
INJECTION SEMAGLUTIDE
POVITZRA 1 MG
Medicine For OBESITY DIABETES |
SQ |
ONCE A WEEK |
SUBCUTANEOUS
|
|
| MAY CAUSE NAUSEA VOMITING | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 08/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP SMBG,BUN CR UACR ,LIPID PROFILE |
| |
|
| |
|
Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu /
48748 HPRID: 71-0638-2075-7542
This is a Computer generated Prescription |
Powered By:  |
|